The Cigna Group — Jan 30, 2025 release

Additionally, this outlook includes the impact of expected future share repurchases, anticipated 2025 dividends and assumes that the previously announced divestiture of the Company’s Medicare businesses will close in the first quarter of 2025. (dollars in millions, except where noted and per share amounts) 2025 Consolidated Metrics Projection for Full Year Ending December 31, 2025 Adjusted Revenues 2,3 at least $252,000 Adjusted Income from Operations 1,2 at least $7,900 Adjusted Income from Operations, per share 1,2 at least $29.50 Adjusted SG&A Expense Ratio 2,4 ~5.4% Adjusted Effective Tax Rate 2,9 ~19.0% Cash Flow from Operations 2 ~$10,000 Capital Expenditures 2 ~$1,400 Shareholder Dividends 2 ~$1,600 Weighted Average Shares Outstanding (millions) 2 266 to 270     2025 Evernorth Metrics   Evernorth Adjusted Income from Operations, Pre-Tax 1,2 at least $7,200     2025 Cigna Healthcare Metrics   Cigna Healthcare Adjusted Income from Operations, Pre-Tax 1,2 at least $4,100 Cigna Healthcare Medical Care Ratio 2,4 83.2% to 84.2% Total Medical Customers 2,5 ~18.1M 7 The foregoing statements represent the Company’s current estimates of The Cigna Group's 2025 consolidated and segment adjusted income from operations 1,2 and other key metrics as of the date of this release.  Actual results may differ materially depending on a number of factors.  Inv